Discover a new study where results suggest that combining systemic and localised treatment can improve tumour control.

Lilly licenses Alchemab’s ALS antibody ATLX-1282 in $415mn deal, expanding its neuroscience pipeline with a novel, ...

Find out how maternal hypertension affects preterm infant brain development and why early intervention is crucial - read more ...

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups - read more about the latest trial ...

Understand how ultrasound-guided PDT improves first-puncture success and reduces bleeding risk compared to landmark guidance.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Discover a recent study where researchers developed a new evolutionary framework centred on immune robustness. Learn more.

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised ...

A new study shows no survival benefit from adding chemotherapy to radiotherapy in intermediate-risk cervical cancer, ...

In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...

New survey reveals what drives referral decisions among rheumatologists, which specialties are most referred to, and how ...

Guselkumab significantly improves clinical remission rates in patients with active ulcerative colitis, according to phase 3 data.